Contrave ER 8-90 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DB25FJPLM
- Awardee
-
Dakota Drug, Inc. UEI H544BCGUKW64
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,153
Award facts
- Contract value 100% obligated
- $18,152.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Anoka, MN, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,152.60 firm fixed-price delivery order to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Contrave ER 8-90 mg tablets (120-count units). The award was made on September 2, 2025, with an ultimate completion date of September 3, 2025, under a non-set-aside procurement. This delivery order is issued under Dakota Drug's existing Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program, which carries a $999,999,999 ceiling and extends through December 31, 2025.
Dakota Drug, Inc. is an established federal pharmaceutical supplier that has demonstrated extensive capability in delivering critical medications to U.S. Armed Forces medical operations. The company's track record with the DLA includes supplying diverse pharmaceutical products spanning diabetes management, respiratory medications, pain management, cardiovascular, and other therapeutic categories. This delivery order for Contrave ER—an obesity management medication—reflects the company's continued role as a strategic vendor in the military medical supply chain and its ability to efficiently fulfill time-sensitive pharmaceutical procurement needs for defense healthcare facilities.
Quick answers
Who was awarded contract SPE2DB25FJPLM?
SPE2DB25FJPLM was awarded to Dakota Drug, Inc. by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FJPLM worth?
The government has obligated $18,153 on SPE2DB25FJPLM.
Is contract SPE2DB25FJPLM an order under another contract?
Yes. SPE2DB25FJPLM is a delivery order under SPE2DB24D8002, an indefinite delivery contract.
Was contract SPE2DB25FJPLM competed?
The extent of competition for SPE2DB25FJPLM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award